Skip to content
Ranked #505
MultiMedRx

Brand-name GLP-1s plus broader cardiometabolic care under one entity.

semaglutide
Not confirmed for MultiMedRx.
tirzepatide
Not confirmed for MultiMedRx.
Before enrolling

No Mounjaro or Foundayo in the brand-name lineup (only Ozempic, Wegovy, Zepbound)

vs
Ranked #18Desk pick
Pallas Health

Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.

semaglutide
$199/mosee conditions
tirzepatide
$299/mosee conditions
Before enrolling

There is no month-to-month rung for either compounded molecule — the funnel renders no cadence selector — so the advertised “$199/mo average” is a single $597 charge every twelve weeks divided by three

Our review of Pallas Health gives it 87/100 (B+), while our review of MultiMedRx gives it 49/100 (C). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

MultiMedRx

49/100

C

Overall

Pallas Health

87/100

B+

Price transparency

20
78

State access

24
94

Molecule range

79
90

Onboarding speed

57
88

Support responsiveness

77
88

Licensing & trust

76
90

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldMultiMedRxPallas Health
SemaglutideNot confirmed for MultiMedRx.$199/mosee conditions
Full plan terms

$199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold)

TirzepatideNot confirmed for MultiMedRx.$299/mosee conditions
Full plan terms

$299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold)

CoverageNot confirmed for MultiMedRx.All 50 states + DC (async in 43; 7 states plus DC require one video visit)
Brand-nameBrand-name option listedBrand-name option listed
Oral optionNot confirmed hereNot confirmed here
Best forBrand-name GLP-1s plus broader cardiometabolic care under one entity.Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.
Desk Score49/100C87/100B+

The verdict

Desk pick — Pallas Health

Pallas Health has the higher Desk Score, but MultiMedRx may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose MultiMedRx if…

Brand-name GLP-1s plus broader cardiometabolic care under one entity.

Choose Pallas Health if…

Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.

$199/mo (see conditions) sema · $299/mo (see conditions) tirz · All 50 states + DC (async in 43; 7 states plus DC require one video visit)

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.